Braden M. Leonard - Apr 11, 2022 Form 4 Insider Report for Gemini Therapeutics, Inc. /DE (IRON)

Role: 10%+ Owner
Signature: Braden Michael Leonard
Stock symbol: IRON
Transactions as of: Apr 11, 2022
Transactions value $: $1,337,929
Form type: 4
Date filed: 4/13/2022, 04:09 PM
Next filing: Apr 25, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IRON	Common Stock	Purchase	$75.1K	+55K	+25.58%	$1.37^*	270K	Apr 12, 2022	Direct	F2
transaction	IRON	Common Stock	Purchase	$681K	+504K	+12.3%	$1.35^*	4.6M	Apr 11, 2022	Holding of BML Investment Partners, L.P.(1)	F1, F3
transaction	IRON	Common Stock	Purchase	$290K	+204K	+4.42%	$1.42^*	4.81M	Apr 12, 2022	Holding of BML Investment Partners, L.P.(1)	F1, F4
transaction	IRON	Common Stock	Purchase	$292K	+192K	+3.99%	$1.52^*	5M	Apr 13, 2022	Holding of BML Investment Partners, L.P.(1)	F1, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Explanation of Responses: 1. BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
F2	The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.355 to $1.40. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
F3	The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.3496 to $1.35. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
F4	The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.35 to $1.45. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
F5	The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.45 to $1.60. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.